Page 270 - Drug Class Review
P. 270
Page 165 of 205
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Evans et al. 94 Year: 2004 NR Study design: Pooled data analysis Number of patients: NR To determine the incidence rates of adverse events for DON, GAL, and RIV 29 RCTs NR RCTs NR
Final Report Update 1 Adverse Events STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN REVIEW TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
